Silo Pharma Inc. (SILO)
NASDAQ (CM) NASDAQ (CM) Primary 
Why Is Silo Pharma (SILO) Stock Up 60% Today?
Developmental-stage pharmaceutical firm Silo Pharma (NASDAQ: SILO ) — which specializes in both traditional and psychedelic therapeutics to address stress-induced psychiatric disorders — saw its shares rise dramatically on Thursday. Earlier this morning, the company announced a partnership to develop an intranasal drug to address post-traumatic stress disorder (PTSD).
Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug
Silo Pharma Inc SILO stock is surging on Thursday, with a session volume of 88 million compared to an average volume of 3.2 million, as per data from Benzinga Pro.
Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?
Silo Pharma Inc SILO shares are trading higher on Tuesday on a high session volume of over 87 million.
Why Is Silo Pharma (SILO) Stock Up 123% Today?
Silo Pharma (NASDAQ: SILO ) stock is rocketing higher on Tuesday after the developmental stage biopharmaceutical company secured a new global license. This license covers the development, manufacturing, and commercialization of its Alzheimer's drug SPC-14.
